• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力的床边和实验室诊断检测。

Bedside and laboratory diagnostic testing in myasthenia.

机构信息

University of Oxford, UK and Oxford University Hospitals, Oxford, UK.

Department of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.

出版信息

J Neurol. 2022 Jun;269(6):3372-3384. doi: 10.1007/s00415-022-10986-3. Epub 2022 Feb 10.

DOI:10.1007/s00415-022-10986-3
PMID:35142871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9119875/
Abstract

Myasthenia gravis (MG) and congenital myasthenic syndromes (CMS) are a group of disorders with a well characterised autoimmune or genetic and neurophysiological basis. We reviewed the literature from the last 20 years assessing the utility of various neurophysiological, immunological, provocative and genetic tests in MG and CMS. Diagnostic sensitivity of repetitive nerve stimulation test ranges between 14 and 94% and specificity between 73 and 100%; sensitivity of single-fibre EMG (SFEMG) test ranges between 64 and 100% and specificity between 22 and 100%; anti-acetylcholine receptor (AChR) antibody sensitivity ranges from 13 to 97% and specificity ranges from 95 to 100%. Overall, SFEMG has the highest sensitivity while positive anti-AChR antibodies have the highest specificity. Newer testing strategies that have been investigated over the last couple of decades include ocular vestibular-evoked myogenic potentials, otoacoustic emissions and disease-specific circulating miRNAs in serum for autoimmune myasthenia, as well as next-generation sequencing for genetic testing of CMS. While there has been significant progress in developing newer testing strategies for diagnosing MG and CMS over the last couple of decades, more research is needed to assess the utility of these newer tools regarding their sensitivity and specificity.

摘要

重症肌无力(MG)和先天性肌无力综合征(CMS)是一组以明确的自身免疫或遗传及神经生理学基础为特征的疾病。我们回顾了过去 20 年的文献,评估了各种神经生理学、免疫学、激发和遗传测试在 MG 和 CMS 中的应用价值。重复神经刺激测试的诊断灵敏度在 14%至 94%之间,特异性在 73%至 100%之间;单纤维肌电图(SFEMG)测试的灵敏度在 64%至 100%之间,特异性在 22%至 100%之间;抗乙酰胆碱受体(AChR)抗体的灵敏度范围为 13%至 97%,特异性范围为 95%至 100%。总的来说,SFEMG 的灵敏度最高,而阳性抗 AChR 抗体的特异性最高。过去几十年中,已经研究了一些新的检测策略,包括眼动前庭诱发肌源性电位、耳声发射和血清中针对自身免疫性重症肌无力的疾病特异性循环 miRNA,以及 CMS 的下一代测序基因检测。尽管在过去几十年中,MG 和 CMS 的诊断检测策略有了显著的发展,但仍需要更多的研究来评估这些新工具的敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/9119875/58b113cf43dc/415_2022_10986_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/9119875/86636deb5f8a/415_2022_10986_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/9119875/58b113cf43dc/415_2022_10986_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/9119875/86636deb5f8a/415_2022_10986_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/9119875/58b113cf43dc/415_2022_10986_Fig2_HTML.jpg

相似文献

1
Bedside and laboratory diagnostic testing in myasthenia.重症肌无力的床边和实验室诊断检测。
J Neurol. 2022 Jun;269(6):3372-3384. doi: 10.1007/s00415-022-10986-3. Epub 2022 Feb 10.
2
Repetitive ocular vestibular evoked myogenic potentials in myasthenia gravis.重症肌无力患者的重复性眼前庭诱发肌源性电位。
Neurology. 2020 Apr 21;94(16):e1693-e1701. doi: 10.1212/WNL.0000000000009306. Epub 2020 Mar 26.
3
Diagnostic sensitivity of the laboratory tests in myasthenia gravis.重症肌无力实验室检查的诊断敏感性
Muscle Nerve. 1992 Jun;15(6):720-4. doi: 10.1002/mus.880150616.
4
Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.先天性肌无力综合征与 COLQ 基因的新型致病性变异相关,这些变异与乙酰胆碱受体抗体的存在有关。
J Clin Neurosci. 2020 Feb;72:468-471. doi: 10.1016/j.jocn.2019.12.007. Epub 2019 Dec 10.
5
Genetic, serological and clinical evaluation of childhood myasthenia syndromes- single center subgroup analysis experience in Turkey.土耳其单中心亚组分析经验:儿童重症肌无力综合征的遗传、血清学和临床评估。
Acta Neurol Belg. 2023 Dec;123(6):2325-2335. doi: 10.1007/s13760-023-02370-3. Epub 2023 Sep 1.
6
[Neurophysiological testing in myasthenia syndromes].[肌无力综合征的神经生理学检测]
Neurol Neurochir Pol. 2003 Jan-Feb;37(1):161-72.
7
Electrophysiological and immunological study in myasthenia gravis: diagnostic sensitivity and correlation.重症肌无力的电生理和免疫学研究:诊断敏感性和相关性。
Clin Neurophysiol. 2011 Sep;122(9):1873-7. doi: 10.1016/j.clinph.2011.02.026. Epub 2011 Mar 17.
8
[Myasthenia gravis should be considered in cases of Parkinson's disease and progressive dysphagia].帕金森病和进行性吞咽困难患者应考虑重症肌无力。
Nervenarzt. 2018 Apr;89(4):443-445. doi: 10.1007/s00115-017-0378-z.
9
Diagnostic accuracy and clinical utility of bed side tests versus laboratory tests in the diagnosis of ocular myasthenia.床边检查与实验室检查在眼肌型重症肌无力诊断中的诊断准确性和临床实用性。
Indian J Ophthalmol. 2022 Apr;70(4):1331-1337. doi: 10.4103/ijo.IJO_2015_21.
10
Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.乙酰胆碱受体抗体检测在眼肌型重症肌无力中的临床应用。
JAMA Neurol. 2015 Oct;72(10):1170-4. doi: 10.1001/jamaneurol.2015.1444.

引用本文的文献

1
Electrodiagnostic criteria for neuromuscular transmission disorders suggested by a European consensus group.欧洲共识小组提出的神经肌肉传递障碍的电诊断标准。
Clin Neurophysiol Pract. 2025 Mar 7;10:79-83. doi: 10.1016/j.cnp.2025.02.011. eCollection 2025.
2
Pitfalls in the Evaluation of Respiratory Failure in Myasthenia Gravis Patients: A Case Series.重症肌无力患者呼吸衰竭评估中的陷阱:病例系列
Neurohospitalist. 2024 Aug 31:19418744241280528. doi: 10.1177/19418744241280528.
3
Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cancer Immunotherapy.

本文引用的文献

1
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.重症肌无力中的自身抗体特异性;对改进诊断和治疗的意义。
Front Immunol. 2020 Feb 14;11:212. doi: 10.3389/fimmu.2020.00212. eCollection 2020.
2
Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors.先天性肌无力综合征与 COLQ 基因的新型致病性变异相关,这些变异与乙酰胆碱受体抗体的存在有关。
J Clin Neurosci. 2020 Feb;72:468-471. doi: 10.1016/j.jocn.2019.12.007. Epub 2019 Dec 10.
3
Importance of clinical tests in ocular myasthenia.
免疫检查点抑制剂相关性肌病:癌症免疫治疗的双刃剑。
Neurology. 2024 Dec 10;103(11):e210031. doi: 10.1212/WNL.0000000000210031. Epub 2024 Nov 8.
4
Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.非编码RNA及其网络在重症肌无力发病机制中的作用
Front Mol Biosci. 2024 Sep 10;11:1388476. doi: 10.3389/fmolb.2024.1388476. eCollection 2024.
5
Paraneoplastic neurological syndromes of small cell lung cancer.小细胞肺癌的副肿瘤性神经系统综合征
Postep Psychiatr Neurol. 2024 Jun;33(2):80-92. doi: 10.5114/ppn.2024.141157. Epub 2024 Jul 11.
6
Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.反复性眼前庭肌源性电位诊断伴眼睑下垂或复视的重症肌无力患者的准确性。
Neurology. 2024 May;102(10):e209395. doi: 10.1212/WNL.0000000000209395. Epub 2024 Apr 26.
7
MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets.抗 MuSK 型重症肌无力-潜在的发病机制和针对特定靶点的治疗方法。
Cells. 2024 Mar 21;13(6):556. doi: 10.3390/cells13060556.
8
Saccadic fatigue as an early indicator for diagnosing myasthenia gravis.眼球运动性疲劳作为诊断重症肌无力的早期指标。
J Neurol. 2024 Jun;271(6):3631-3634. doi: 10.1007/s00415-024-12262-y. Epub 2024 Feb 25.
9
Immunosensors for Autoimmune-Disease-Related Biomarkers: A Literature Review.用于自身免疫疾病相关生物标志物的免疫传感器:文献综述。
Sensors (Basel). 2023 Jul 28;23(15):6770. doi: 10.3390/s23156770.
10
Development and Assessment of an Artificial Intelligence-Based Tool for Ptosis Measurement in Adult Myasthenia Gravis Patients Using Selfie Video Clips Recorded on Smartphones.基于人工智能的工具用于通过智能手机录制的自拍视频片段测量成年重症肌无力患者上睑下垂的开发与评估
Digit Biomark. 2023 Jul 28;7(1):63-73. doi: 10.1159/000531224. eCollection 2023 Jan-Dec.
临床检查在眼肌型重症肌无力中的重要性。
BMJ Case Rep. 2019 Dec 8;12(12):e231296. doi: 10.1136/bcr-2019-231296.
4
Sensitivity and specificity of single-fibre EMG in the diagnosis of ocular myasthenia varies accordingly to clinical presentation.单纤维肌电图在诊断眼肌型重症肌无力中的敏感性和特异性随临床表现而变化。
J Neurol. 2020 Mar;267(3):739-745. doi: 10.1007/s00415-019-09631-3. Epub 2019 Nov 16.
5
Consideration of repetitive nerve stimulation of the median nerve in patients being evaluated for myasthenia gravis.考虑对正在接受重症肌无力评估的患者进行正中神经重复神经刺激。
Muscle Nerve. 2019 Dec;60(6):658-661. doi: 10.1002/mus.26713. Epub 2019 Oct 9.
6
Clinical analysis of Chinese anti-low-density-lipoprotein-receptor-associated protein 4 antibodies in patients with myasthenia gravis.中国抗低密度脂蛋白受体相关蛋白 4 抗体在重症肌无力患者中的临床分析。
Eur J Neurol. 2019 Oct;26(10):1296-e84. doi: 10.1111/ene.13979. Epub 2019 Jun 2.
7
Congenital myasthenic syndromes.先天性肌无力综合征。
Orphanet J Rare Dis. 2019 Feb 26;14(1):57. doi: 10.1186/s13023-019-1025-5.
8
Evaluation and validation of sustained upgaze combined with the ice-pack test for ocular myasthenia gravis in Asians.评估和验证亚洲人眼肌型重症肌无力持续上视与冰袋试验的联合应用。
Neuromuscul Disord. 2019 Apr;29(4):296-301. doi: 10.1016/j.nmd.2018.12.011. Epub 2018 Dec 22.
9
Abnormalities of Otoacoustic Emissions in Myasthenia Gravis: Association With Serological and Electrophysiological Features.重症肌无力患者耳声发射异常:与血清学及电生理特征的关联
Front Neurol. 2018 Dec 20;9:1124. doi: 10.3389/fneur.2018.01124. eCollection 2018.
10
Repetitive nerve stimulation test in myasthenic crisis.重复神经刺激试验在重症肌无力危象中的应用。
Muscle Nerve. 2019 May;59(5):544-548. doi: 10.1002/mus.26390. Epub 2019 Jan 9.